B型利钠肽对心肌梗死后左室重构的随机试验
该随机试验纳入58例成功血运重建的急性ST段抬高前壁心肌梗死患者,比较72小时输注B型利钠肽(BNP)0.006 µg/kg/min与安慰剂的效应。结果显示两组30天左室容积与射血分数变化无显著差异,BNP未改善左室重构参数,不支持心梗后静脉使用BNP。
要点
- BNP输注未显著改善心梗后30天左室容积或射血分数。
- 基线射血分数<40%者BNP组梗死面积有减少趋势但未达显著。
- 结果不支持对近期心梗患者静脉使用BNP。
核心结论
- 前壁心梗患者输注BNP未影响左室重构参数。
- 基线左室射血分数<40%的BNP治疗者梗死面积有减少趋势。
- 结果不支持近期心梗后静脉使用BNP。
研究设计与样本
- 随机试验纳入58例成功血运重建的急性ST段抬高前壁心肌梗死患者。
- 患者随机接受72小时BNP输注0.006 µg/kg/min或安慰剂。
- 基线及30天用多门控采集扫描测左室舒张末、收缩末容积和射血分数,心脏MRI测梗死面积。
主要发现
- BNP输注组72小时BNP及血浆环磷酸鸟苷水平显著更高。
- 两组基线至30天左室容积或射血分数变化无显著差异。
- 心脏MRI测梗死面积两组无显著差异(p=0.39)。
- 基线射血分数<40%者BNP组梗死面积有减少趋势(p=0.14)。
临床怎么用
- 不推荐对近期前壁心梗患者常规静脉使用BNP以改善左室重构。
- 基线射血分数<40%者的梗死面积趋势需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: B-type natriuretic peptide (BNP) has favourable effects on left ventricular remodelling, including antifibrotic and antiapoptotic properties. We tested the hypothesis that infusion of BNP after an acute myocardial infarction would reduce left ventricular systolic and diastolic volumes and improve left ventricular ejection fraction compared with placebo. METHODS: A total of 58 patients who underwent successful revascularisation for an acute ST elevation anterior myocardial infarction were randomised to receive 72-hour infusion of BNP at 0.006 µg/kg/min or placebo. Left ventricular end diastolic and systolic volumes and left ventricular ejection fraction were measured at baseline and at 30 days by multigated acquisition scan. Left ventricular infarction size was measured by cardiac MRI. RESULTS: BNP infusion led to significantly higher BNP levels and plasma cyclic guanosine monophosphate at 72 hours. No significant difference in change of left ventricular volumes or ejection fraction from baseline to 30 days was observed between groups. Although left ventricular infarction size measured by cardiac MRI was not significantly different between BNP infusion versus placebo (p=0.39), there was a trend towards reduced infarction size in patients with a baseline ejection fraction of <40% (p=0.14). CONCLUSIONS: Infusion of BNP in patients with an anterior myocardial infarction did not affect parameters of left ventricular remodelling. Patients treated with BNP who had a baseline left ventricular ejection fraction of <40% had a trend towards reduced left ventricular infarction size compared with placebo. These results do not support the use of intravenous BNP in patients after recent myocardial infarction. TRIAL REGISTRATION NUMBER: NCT00573144.
引用
- Hubers SA, Schirger JA, Sangaralingham SJ, et al. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial. Heart. 2020. PMID: 32747497. doi:10.1136/heartjnl-2020-317182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。